Pillstats
Rx only · Solution · Oral

Enalapril Maleate

Brands: Epaned · Enalapril Maleate

6 ACTIVE SUPPLIERS — US
openFDA · updated weekly
US6 NDCs
6 active makers
UKComing
soon
CAComing
soon
AUComing
soon
EUComing
soon
RxCUI (US)3827
US makers6 labelers
Packages6
DEA / ScheduleNone

US acquisition costNADAC · per unit

Average across 6 priced NDCs. A benchmark of pharmacy acquisition cost — not a retail quote.

$0.475$0.950$1.43$1.90Dec 2025Mar 2026Jul 2026
$1.516
Latest avg · Jul 22, 2026
+51%
Since Dec 17, 2025
6
Active US suppliers
33%
Top-2 supplier share*

Medicaid dispensing volumeSDUD · per quarter

Prescriptions dispensed under Medicaid (fee-for-service + managed care), summed nationally. The closest free proxy to sales volume — Medicaid only, not all-payer.

6.4K13K19K25K2025 Q12025 Q22025 Q32025 Q42026 Q1
21K
Rx · 2026 Q1
3.1M
Units dispensed
+6%
Rx vs. year ago
5
Quarters · since 2025 Q1

Who makes it6 active · 0 exited

US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.

LabelerTypePackagesStatus
NorthStar RxLLCunknown1SUPPLYING
Aurobindo Pharma Limitedunknown1SUPPLYING
Azurity Pharmaceuticals, Inc.unknown1SUPPLYING
Camber Pharmaceuticals, Inc.unknown1SUPPLYING
Wilshire Pharmaceuticals, Inc.unknown1SUPPLYING
Bionpharma Inc.unknown1SUPPLYING

Regulatory & supply events

No recalls, shortages, or registration changes on record for this drug concept.